ESC Premium Access

Risks and benefits of anticoagulation in the elderly - Insights from randomized trials

Topic: Treatment
Sponsored by Daiichi Sankyo Europe GmBH


About the speaker

Doctor Robert Patrick Giugliano

Brigham and Women's Hospital, Department of Medicine, Cardiovascular Division, TIMI Study Group, Boston (United States of America)
9 presentations
0 follower

4 more presentations in this session

Welcome and introduction

Speaker: Professor C. Bode (Freiburg, DE)


Challenges in the treatment of the elderly atrial fibrillation patient

Speaker: Professor R. De Caterina (Pisa, IT)


The elderly patient in daily practice – further guidance from observational data

Speaker: Professor J. Steffel (Zurich, CH)


Panel discussion and conclusion

Speaker: Professor R. De Caterina (Pisa, IT) Professor C. Bode (Freiburg, DE)


Access the full session

Anticoagulation in the aging atrial fibrillation population

Speakers: Doctor R. Giugliano, Professor C. Bode, Professor R. De Caterina, Professor J. Steffel, Professor R. De Caterina...

About the event



31 August - 4 September 2019

Sessions Presentations

Related content

ESC Premium Access

Meet the Experts: hypertension, atrial fibrillation and dementia – discussion

30 August 2021

ESC Premium Access

Atrial fibrillation: moving beyond stroke to cognition.

30 August 2021

ESC Premium Access

Benefits of SGLT2-1/2 Inhibition on Heart Failure, Ischemic, and Kidney Endpoints

27 August 2021

This platform is supported by

logo Novo Nordisk